Podcast Episodes
Back to Search
Episode 92: The decade in breakthroughs, the year in bad CEOs, and the viruses that cure disease
Which drug defined the decade? Who's the worst CEO in biopharma? And how does gene therapy actually work?
6 years, 10 months ago
Episode 91: CAR-T's future, an alarming cancer trend & Chris Garabedian on Sarepta's FDA legacy
Has CAR-T lost its luster? Why is colorectal cancer on the rise? And did the FDA forever change in 2016?
6 years, 10 months ago
Episode 90: Biogen's big reveal, hot takes on Alzheimer's, & the science of one-eyed sheep
How do you know if a "positive" study is positive? And how did one-eyed sheep lead to a drug for certain cancers?
6 years, 10 months ago
Episode 89: Warren's awkward home front, a dwarfism drug, and the sound of STAT Summit
Can Sen. Elizabeth Warren ever go home again? Is it ethical to make little people taller? And when will AI come up with a new drug?
6 years, 10 months ago
Episode 88: Dr. David Sable on an alarming genetic test & Jorge Conde on the perils of bio-Twitter
Do you trust Google with your health data? Is "Gattaca" an outdated reference? And what's it like to get dunked on?
6 years, 11 months ago
Episode 87: Derek Lowe on China's new Alzheimer's drug, blockbuster fish oil, & STAT's birthday
Why hope for China's new Alzheimer's drug turned into skepticism ? Is three a crowd in CAR-T? And what's a Bionomy?
6 years, 11 months ago
Episode 86: Drugs that don't work, wearables in the desert, & excess 'innovation'
When should a drug be pulled from shelves? How do you pronounce "HLTH?" And how does Ann Coulter decide what to tweet?
6 years, 11 months ago
Episode 85: Every angle on Biogen's shocking Alzheimer's news
What exactly is Biogen doing? When is a press release worth $12 billion? And what should patients make of whiplashing news? We're devoting this entir…
6 years, 11 months ago
Episode 84: CRISPR with Netflix filmmakers, Pharma's future in China & where VC dollars come from
Should drug companies be free-speech advocates? Is your retirement dependent on CRISPR? And how useful is a glow-in-the-dark dog?
7 years ago
Episode 83: How biotech VC works w/ health care journalist Maggie Fox, Vioxx and synthetic biology
STAT's Matthew Herper joins us to dig into the history of the infamous pain drug Vioxx and a new effort to bring it back as a rare disease treatment.…
7 years ago